Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nyxoah (NYXH) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Nyxoah (NYXH) over the last 5 years, with Q3 2025 value amounting to $2078.6.

  • Nyxoah's Shares Outstanding (Diluted Average) rose 4061.53% to $2078.6 in Q3 2025 from the same period last year, while for Sep 2025 it was $2078.6, marking a year-over-year increase of 4061.53%. This contributed to the annual value of $1.9 million for FY2024, which is 1628.81% up from last year.
  • Per Nyxoah's latest filing, its Shares Outstanding (Diluted Average) stood at $2078.6 for Q3 2025, which was up 4061.53% from $1300.6 recorded in Q2 2025.
  • Over the past 5 years, Nyxoah's Shares Outstanding (Diluted Average) peaked at $1.9 million during Q4 2024, and registered a low of $291.81 during Q1 2022.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $360839.4, with a median of $1088.5 in 2021.
  • As far as peak fluctuations go, Nyxoah's Shares Outstanding (Diluted Average) tumbled by 9992.96% in 2022, and later surged by 10432.4% in 2023.
  • Over the past 5 years, Nyxoah's Shares Outstanding (Diluted Average) (Quarter) stood at $1.3 million in 2021, then decreased by 7.13% to $1.2 million in 2022, then surged by 34.77% to $1.7 million in 2023, then grew by 16.29% to $1.9 million in 2024, then crashed by 99.89% to $2078.6 in 2025.
  • Its Shares Outstanding (Diluted Average) was $2078.6 in Q3 2025, compared to $1300.6 in Q2 2025 and $629.03 in Q1 2025.